SWIA’s COPD Study is searching for participants aged above 40 years old
You may be eligible for a study and receive compensation for time and travel
Sign up here or contact us and our research coordinator will be in touch for screening.
image: freepik
COPD Therapy Study
A research study to evaluate COPD treatment in participants with Symptomatic Chronic Obstructive Pulmonary Disease (COPD) with a History of COPD Exacerbations (OBERON) is open for enrollment. Study-related procedures and study medication are covered at no cost to you. Participants who qualify will be compensated for time and reasonable expenses for their visits. It is a great opportunity to receive close care by doctors you trust.
View this study on Clinicaltrial.gov: https://clinicaltrials.gov/study/NCT055740102
What is Celiac Disease? Read our info page: https://asthma2.com/news/asthma-resources
Eligibility Requirements:
– Be 40 years old or above
– Be diagnosed with COPD for at least 1 year at the time the study begins
Study Details:
– This Phase III study evaluates a potential treatment which aims to reduce symptoms and exacerbations in people with chronic obstructive pulmonary disease (COPD).
If you or someone you know may be interested, please sign up in our interest form. Our clinical trial staff will contact you for screening.
Contact us for more information, SWIA Clinical Research Dept.: Stephanie 309-451-7509 or email us at research@asthma2.com
______________________________
Why participate in clinical research? All of the medicines you currently take for your health were first studied in clinical trials before the FDA approved them. It is a great way to help your community, while getting close care and monitoring by doctors you know.
See other active clinical trials here.
Page updated: January 2025 (study valid until 2026)
